Claus van der Velden's most recent trade in Anavex Life Sciences Corporation was a trade of 50,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 31, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Anavex Life Sciences Corpo... | Claus van der Velden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
Anavex Life Sciences Corpo... | van der Velden Claus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
Anavex Life Sciences Corpo... | Claus van der Velden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
Anavex Life Sciences Corpo... | Claus van der Velden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
Anavex Life Sciences Corpo... | Claus van der Velden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) |